Hamlin Capital Management, LLC, a registered investment adviser, initiated a new position in Johnson & Johnson (NYSE:JNJ) during Q4 2025, according to its most recent 13F filing with the Securities and Exchange Commission.
The institutional investor purchased 836,098 shares of the Healthcare company, valued at approximately $173,030,481 as of the filing date.
Johnson & Johnson's stock currently trades at $207.49 with a market capitalization of $505,783,320,763.
